Citius Pharmaceuticals Reports Positive Results from Recent Data Monitoring Committee Meeting for Mino-Lok Phase 3 Trial Sep 29, 2020
Citius Pharmaceuticals Achieves Chemical Manufacturing and Control Milestones for Mino-Lok® Sep 22, 2020
Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance Sep 15, 2020
Citius Pharmaceuticals to Present at H.C. Wainwright Virtual 22nd Annual Global Investment Conference Sep 8, 2020
Citius Pharmaceuticals Announces Improved Design and Expansion of Intellectual Property for Mino-Wrap Aug 26, 2020
Citius Pharmaceuticals Announces Closing of $9.6 Million Bought Deal Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares Aug 10, 2020
Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million Aug 5, 2020
